Novartis CDR (CAD Hedged) (NVS:TSX) closed at $29.71 on October 23, 2026, down 3.07% on the day. The stock trades 5.5% below its 52-week high of $31.43 and 28.6% above its 52-week low of $23.10. Over the past year, it gained 21.5%. Novartis CDR (CAD Hedged) is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, NVS closed higher on 130 days (52%). Its best day was September 1, 2026 (+6.08%) and its worst was September 8, 2026 (-15.19%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 1 time.
Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue.
Find more stocks like NVS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.